Clinical Trial Update: BIYELA - Bexsero Immunisation in Young Women in Africa [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for BIYELA, a Bexsero immunisation study in young African women evaluating gonorrhea prevention; the trial is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Drugs mentioned

• Bexsero (Meningococcal group B vaccine (4CMenB))

Snippet

Sponsor: University of Washington | Conditions: Gonorrhea, Gonorrhea of Pharynx | Phase 3 | Status: ACTIVE_NOT_RECRUITING